U.S. Machinery Stock News

Why the latest PAPZIMEOS endorsement matters for Precigen Precigen (PGEN) is back in focus after a new consensus paper from 16 physicians recommended its drug PAPZIMEOS as the standard of care for adults with recurrent respiratory papillomatosis, building on recent US and European regulatory milestones. See our latest analysis for Precigen. Precigen’s share price has moved to $4.74, with an 11.79% 7 day share price return and 13.67% 30 day share price return, while the 1 year total...

First American Financial (FAF) just wrapped up FY 2025 with Q4 revenue of US$2.0 billion and basic EPS of US$2.06, supported by trailing 12 month revenue of US$7.5 billion and EPS of US$6.02. Over recent quarters, the company has seen revenue move from US$1.6 billion and EPS of US$0.71 in Q1 2025 to US$2.0 billion and EPS of US$2.06 in Q4 2025, while trailing net profit margin sits at 8.3% compared with 2.1% a year earlier. This points to a period where profitability has become a much bigger...

Sylvamo (SLVM) just posted its FY 2025 third quarter numbers, reporting revenue of US$846 million and basic EPS of US$1.43 alongside net income of US$57 million. The company’s quarterly revenue moved from US$970 million in Q4 2024 to US$821 million in Q1 2025, US$794 million in Q2, and then US$846 million in Q3. Over the same period, basic EPS went from US$1.98 to US$0.67, US$0.37, and then US$1.43. These shifts give investors more detail for evaluating how recent performance trends relate to...

In early February 2026, McCune Law Group filed a wrongful death lawsuit against Abbott Diabetes Care and Abbott Laboratories over alleged accuracy defects in FreeStyle Libre 3 glucose sensors, following prior Class I safety actions and an FDA-classified serious device concern affecting about 3 million sensors. At the same time, Abbott has been highlighting strong clinical results across its cardiac device portfolio and raising its dividend, underscoring the tension between product...

If you are wondering whether BILL Holdings is attractively priced or still carrying a premium, this article will walk through what the numbers actually say about its current valuation. The shares last closed at US$46.37, after a 30% gain over the past 7 days, set against declines of 9.5% over 30 days, 8.3% year to date and 23.8%, 52.0% and 74.2% over the past 1, 3 and 5 years respectively. Recent coverage of BILL Holdings has focused on its role in software for automating financial workflows...

Tenet Healthcare (NYSE:THC) has completed a transaction with CommonSpirit Health involving its Conifer Health Solutions subsidiary. The deal reshapes Tenet's relationship with Conifer, a key provider of revenue cycle management and related services to health systems. Investors are watching for implications for Tenet's business mix, capital allocation, and long term operating focus. For you as an investor, this matters because Conifer sits at the intersection of hospital operations and...

Hartford Insurance Group (NYSE:HIG) is integrating its benefits offerings with Centro Benefits Research's digital broker carrier platform. The move aligns with findings from Hartford's Future of Benefits Study on employer demand for simpler, tech driven benefits solutions. The collaboration focuses on streamlining how brokers and employers access and manage Hartford's employee benefits products. For investors watching NYSE:HIG, the integration with Centro Benefits Research arrives as the...

As February begins, the United States stock markets have shown strong performance, with major indices like the Dow Jones Industrial Average and S&P 500 experiencing significant gains. This positive momentum in the market presents an opportunity to explore stocks that may be undervalued, potentially trading below their estimated intrinsic value. Identifying such stocks requires a keen understanding of current market conditions and economic indicators to evaluate their true potential amidst...

As February begins, U.S. stock markets have shown a strong start with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains, reflecting positive investor sentiment amid economic developments such as a new trade deal with India. In this thriving market environment, companies that exhibit high insider ownership often signal confidence from those who know the business best, making them potentially attractive options for growth-focused investors seeking...

As February 2026 begins, major U.S. stock indexes have shown robust performance, with the Dow Jones Industrial Average gaining 515 points and the S&P 500 nearing record highs. This market momentum sets a promising backdrop for exploring investment opportunities in various sectors. Despite its somewhat outdated terminology, the concept of penny stocks remains significant as these smaller or newer companies can offer a blend of affordability and growth potential when backed by strong financials...

As February 2026 begins, the U.S. stock market is experiencing a surge, with major indices like the Dow Jones and S&P 500 showing strong performances despite recent economic uncertainties such as delayed jobs data due to a government shutdown and shifting trade dynamics. In this vibrant yet complex environment, discovering lesser-known stocks that have potential for growth can be an intriguing prospect for investors looking to diversify their portfolios amidst evolving market conditions.

Cohu (NasdaqGS:COHU) reported strong Q4 revenue growth alongside a larger than expected quarterly loss. Management pointed to increasing demand tied to high-bandwidth memory and AI related markets. The company highlighted design wins and solid order activity in automotive, computing, and advanced packaging. Cohu, which supplies test and handling equipment for semiconductor manufacturing, is focusing on areas where chip complexity and performance requirements are rising. High-bandwidth...

Crocs (CROX) has released its FY 2025 figures, reporting Q3 revenue of US$996.3 million and basic EPS of US$2.72. This sits alongside a trailing 12-month profile showing total revenue of about US$4.1 billion and basic EPS of US$3.27. Over recent quarters, the company’s revenue has remained within a relatively narrow range between US$937.3 million and US$1.15 billion. Basic EPS, however, has been more volatile, shifting from a Q2 loss of US$8.82 per share to positive results in Q1 and Q3...

If you are wondering whether Ball's current share price really reflects what the business is worth, this article walks through the key valuation angles to help you frame that question clearly. Over the short term, Ball's share price has moved by 0.8% over the last week, 20.2% over the last month, 25.1% year to date, with a 37.4% return over 1 year and 21.3% over 3 years, compared with a 21.4% decline over 5 years. Taken together, these figures give a mixed picture of how the market has...

Primerica (PRI) has capped FY 2025 with fourth quarter revenue of US$853.7 million, basic EPS of US$6.16 and net income of US$197.0 million, alongside a combined ratio of 66.3% that gives an immediate read on underwriting profitability. The company has seen quarterly revenue move from US$803.4 million and basic EPS of US$4.99 in Q4 2024 to US$853.7 million and US$6.16 in Q4 2025. Trailing 12 month revenue sits at about US$3.3 billion and EPS at US$23.02, setting the stage for investors to...

Similarweb (SMWB) has drawn fresh attention after launching AI Studio, an enterprise AI intelligence platform that lets clients query its extensive digital data through conversational research, deep reports, and auto generated dashboards for business decision support. See our latest analysis for Similarweb. The AI Studio launch and Bloomberg Terminal integration arrive during a weak patch for the stock, with Similarweb’s 30 day share price return of 39.16% and year to date share price return...

Matic recently announced a partnership with nCino to embed its home insurance marketplace directly into nCino’s mortgage point of sale platform, allowing borrowers to shop for coverage within the digital loan process. This integration extends nCino’s mortgage workflow into adjacent insurance services, potentially making its platform more valuable to both lenders and borrowers. Next, we’ll examine how embedding Matic’s home insurance marketplace into nCino’s mortgage platform could influence...

If you are trying to figure out whether CAVA Group's share price lines up with its fundamentals, the valuation story is where things start to get interesting. The stock last closed at US$63.61, with a 7 day return of a 1.5% decline, a 30 day return of a 7.2% decline, a year to date return of 5.1% and a 1 year return of a 51.3% decline, which may catch the eye of investors thinking about potential upside or changing risk. Recent coverage around CAVA Group has mainly focused on its position...

If you are wondering whether Synchrony Financial's current share price reflects its true worth, you are not alone. This article is built to help you size that up. The stock closed at US$71.11, with returns of a 3.9% decline over 7 days, an 8.9% decline over 30 days, a 16.0% decline year to date, but a 13.0% gain over 1 year, 113.4% over 3 years and 117.1% over 5 years. Recent price moves sit against a backdrop of ongoing focus on consumer credit trends, funding costs and card spending...

Bitdeer Technologies Group (NasdaqCM:BTDR) just posted its FY 2025 third quarter numbers with revenue of US$169.7 million, a basic EPS loss of US$1.28 per share and net income loss of US$266.7 million, putting profitability firmly in focus for investors. The company has seen quarterly revenue move from US$70.1 million in Q1 2025 and US$155.6 million in Q2 2025 to US$169.7 million in Q3. Over the same period, EPS moved from a profit of US$2.15 in Q1 to losses of US$0.76 and US$1.28 in Q2 and...

IQVIA Holdings (NYSE:IQV) has entered a collaboration with the Duke Clinical Research Institute to advance clinical research in obesity and cardiometabolic trials. The partnership focuses on complex clinical programs and aims to broaden access to diverse patient groups in areas of rising healthcare focus. For investors watching IQVIA Holdings at a share price of $168.85, this new collaboration sits against a backdrop of weak recent returns. The stock has declined 6.7% over the past week,...

Safehold (NYSE:SAFE) received an S&P credit rating upgrade to A- with a stable outlook. The company announced a share buyback program alongside plans to monetize more of its unrealized capital appreciation, known as "Carats." Management outlined an expansion of ground lease originations, including a focus on affordable housing and broader geographic reach. Safehold, trading at $14.84, is working to reposition itself in the eyes of both credit markets and equity investors. The stock is up...

N-able (NYSE:NABL) announced its Empower 2026 conference, centered on business resilience in cybersecurity. The event will spotlight emerging technology trends, expanded technical tracks, and interactive workshops. Empower 2026 is positioned as a forum for business leaders and IT professionals to address evolving cyber risks. N-able, known for its software solutions that support managed service providers and IT teams, is using Empower 2026 to put cybersecurity resilience front and center...

Avadel Pharmaceuticals (AVDL) has drawn investor attention after recent trading left the shares around $21.64, prompting fresh interest in how its narcolepsy focused portfolio and current fundamentals line up for long term holders. See our latest analysis for Avadel Pharmaceuticals. While the recent 1 day share price return of around 0.05% at US$21.64 and a 30 day share price return of 0.65% suggest only modest short term movement, the 1 year total shareholder return of 151.34% points to...